[PDF][PDF] Current strategies for the inhibition of hepatic glucose production in type 2 diabetes
DS Edgerton, KM Johnson, AD Cherrington - Front Biosci, 2009 - article.imrpress.com
DS Edgerton, KM Johnson, AD Cherrington
Front Biosci, 2009•article.imrpress.com[Frontiers in Bioscience 14, 1169-1181, January 1, 2009] 1169 Current strategies for the
inhibition of hepatic glucose productio Page 1 [Frontiers in Bioscience 14, 1169-1181, January
1, 2009] 1169 Current strategies for the inhibition of hepatic glucose production in type 2
diabetes Dale S. Edgerton, Kathryn MS Johnson, Alan D. Cherrington Department of Molecular
Physiology and Biophysics, Vanderbilt University Medical Center, Nashville TN, 37232-0615,
USA TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Metformin 4. Thiazolidinediones 5 …
inhibition of hepatic glucose productio Page 1 [Frontiers in Bioscience 14, 1169-1181, January
1, 2009] 1169 Current strategies for the inhibition of hepatic glucose production in type 2
diabetes Dale S. Edgerton, Kathryn MS Johnson, Alan D. Cherrington Department of Molecular
Physiology and Biophysics, Vanderbilt University Medical Center, Nashville TN, 37232-0615,
USA TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Metformin 4. Thiazolidinediones 5 …
Abstract
Introduction 3. Metformin 4. Thiazolidinediones 5. Insulin analogs and secretagogues 6. Incretins, incretin mimetics and dipeptidyl peptidase-4 inhibitors 7. Pramlintide
article.imrpress.com